MICROBIAL EPIDEMIOLOGY OF SEPSIS AND SEPTIC SHOCK: WORLDWIDE, SOUTH ASIA, AND CENTRAL ASIA

Sharma Namrata

Authors

Sharma Namrata Asia International University

Keywords:

Microbial Epidemiology of Sepsis and Septic Shock

Abstract

Sepsis and septic shock remain leading causes of illness and death worldwide and represent final pathways of severe infection by diverse pathogens. The microbial causes of sepsis are continually evolving, driven by patterns of antibiotic use, healthcare practices, vaccination coverage, and socioeconomic conditions. Gramnegative bacilli, Grampositive cocci, fungi, and, in some settings, viral and parasitic pathogens all contribute, with an increasing share of cases associated with multidrugresistant (MDR) organisms. This review outlines current concepts and definitions of sepsis and septic shock, summarizes global epidemiology with a focus on South Asia and Central Asia, and examines principal microbial etiologies and resistance profiles. It also reviews key principles of diagnosis, empiric treatment, antimicrobial stewardship, and prevention.

References

Singer M, Deutschman CS, Seymour CW, ShankarHari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis3). JAMA. 2016 Feb 23;315(8):801–10.

Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsisassociated organ dysfunction in children. Intensive Care Med. 2020 Feb;46(Suppl 1):10–67.

Schlapbach LJ, Kissoon N. Defining pediatric sepsis. JAMA Pediatr. 2018 Sep 1;172(2):117–8.

Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020 Jan 18;395(10219):200–11.

Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospitaltreated sepsis: current estimates and limitations. Am J Respir Crit Care Med. 2016 Feb 1;193(3):259–72.

FleischmannStruzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018 Mar;6(3):223–30.

Vincent JL, Sakr Y, Singer M, MartinLoeches I, Machado FR, Marshall JC, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020 May 19;323(15):1478–87.

Kumar G, Kumar N, Taneja A, Kaleekal T, Tarima S, McGinley E, et al. Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest. 2011 Nov;140(5):1223–31.

Kollef MH, Micek ST. Sepsis and septic shock: evolving definitions, epidemiology, and treatment strategies. Crit Care Clin. 2015 Jul;31(4):795–815.

World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2024. Geneva: WHO; 2024.

Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med. 2016 Mar;13(3):e1001974.

O’Brien KL, Wolfson LJ, Watt JP, Henkle E, DeloriaKnoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009 Sep 12;374(9693):893–902.

Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007 Jan;20(1):133–63.

Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospitalacquired multidrugresistant fungal infections globally. PLoS Pathog. 2017 May;13(5):e1006290.

Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018 Jul 7;392(10141):75–87.